Literature DB >> 35402207

Outcomes of extended surgical resections for locally advanced thymic malignancies: a narrative review.

Davide Tosi1, Francesco Damarco1, Sara Franzi1, Shehab Mohamed2, Alessandro Palleschi1,2, Paolo Mendogni1.   

Abstract

Background and Objective: Thymic malignancies represent the most common anterior mediastinal neoplasms, as well as rare and challenging tumors. Surgery is the cornerstone in the treatment of thymic malignancies, although a multidisciplinary approach is mandatory, for both, locally advanced or metastatic disease. In our narrative review, we explored the recent literature to investigate clinical and radiological assessment, multimodality approach and outcomes of locally advanced thymic tumors. More than one-third of patients affected by an anterior mediastinal mass are asymptomatic at diagnosis. In case of locally advanced thymoma, symptoms are related to compression or invasion of adjacent structures, such as the superior vena cava (SVC), innominate veins and pericardium. Paraneoplastic syndromes, such as myasthenia gravis (MG), are related to release of antibodies, hormones and cytokines.
Methods: Diagnostic methods must be chosen accurately to avoid unnecessary surgical resections, to define the best strategy of care, and to plan the surgical strategy. Therefore, each case must be evaluated in a multidisciplinary context, where surgery plays an essential role. Key Content and Findings: In this narrative review, we describe indications and surgical techniques for the treatment of locally advanced thymoma; focusing on oncological outcomes after different approaches. Conclusions: In conclusion, aggressive surgery is always indicated, when possible, and when a complete resection can be planned, yet, the multidisciplinary approach is mandatory, in case of both locally or metastatic advanced disease. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Thymic malignancies; mediastinal surgery; multimodality treatment; myasthenia gravis (MG); superior vena cava infiltration (SVC infiltration)

Year:  2022        PMID: 35402207      PMCID: PMC8984987          DOI: 10.21037/gs-21-642

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  43 in total

1.  Temporary bypass for superior vena cava reconstruction with Anthron bypass tubeTM.

Authors:  Keitaro Matsumoto; Naoya Yamasaki; Tomoshi Tsuchiya; Takuro Miyazaki; Ryotaro Kamohara; Go Hatachi; Takeshi Nagayasu
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.

Authors:  Lorenzo Spaggiari; Francesco Leo; Giulia Veronesi; Piergiorgio Solli; Domenico Galetta; Brunilda Tatani; Francesco Petrella; Davide Radice
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

3.  Surgical treatment of complex malignant anterior mediastinal tumors invading the superior vena cava.

Authors:  Ke-Neng Chen; Shao-Fa Xu; Zhen-Dong Gu; Wei-Min Zhang; Hong Pan; Wen-Zhong Su; Ji-You Li; Guang-Wei Xu
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

4.  Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database.

Authors:  Yoshito Yamada; Ichiro Yoshino; Jun Nakajima; Shinichiro Miyoshi; Takamasa Ohnuki; Makoto Suzuki; Takeshi Nagayasu; Akinori Iwasaki; Meinoshin Okumura
Journal:  Ann Thorac Surg       Date:  2015-07-07       Impact factor: 4.330

5.  Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa).

Authors:  Giuseppe Cardillo; Francesco Carleo; Roberto Giunti; Michele Giovanni Lopergolo; Lorenzo Salvadori; Alessia Raffaella De Massimi; Lea Petrella; Massimo Martelli
Journal:  Eur J Cardiothorac Surg       Date:  2009-11-30       Impact factor: 4.191

6.  Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project.

Authors:  Bernhard Moser; Elie Fadel; Dominique Fabre; Shaf Keshavjee; Marc de Perrot; Pascal Thomas; Geoffrey Brioude; Dirk Van Raemdonck; Sophie Viskens; Loic Lang-Lazdunski; Andrea Bille; Walter Weder; Wolfgang Jungraithmayr; Enrico Ruffini; Francesco Guerrera; David Gómez de Antonio; Moishe Liberman; Nuria Novoa; Marco Scarci; Stefan Janik; Walter Klepetko
Journal:  Eur J Cardiothorac Surg       Date:  2017-08-01       Impact factor: 4.191

7.  Surgical outcomes of 215 patients with thymic epithelial tumors: A single-center experience.

Authors:  Wenxin Tian; Yaoguang Sun; Qingjun Wu; Peng Jiao; Chao Ma; Hanbo Yu; Chuan Huang; Hongfeng Tong
Journal:  Thorac Cancer       Date:  2020-05-08       Impact factor: 3.500

8.  The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature.

Authors:  Alessio Bruni; Alessandro Stefani; Marco Perna; Paolo Borghetti; Niccolò Giaj Levra; Elisa D'Angelo; Alessandra D'Onofrio; Laura Rubino; Luca Frassinelli; Viola Salvestrini; Matteo Mariotti; Filippo Alongi; Alessandro Gonfiotti; Lorenzo Livi; Vieri Scotti
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

9.  Salvage surgery for stage IVa thymic carcinoma combined with aortic arch resection - case report.

Authors:  Hiroyuki Yamato; Soichiro Funaki; Kazuo Shimamura; Keiwa Kin; Toru Kuratani; Yoshiki Sawa; Yasushi Shintani
Journal:  J Cardiothorac Surg       Date:  2020-10-07       Impact factor: 1.637

10.  Extended thymectomy with blood vessel resection and reconstruction improves therapeutic outcome for clinical stage III thymic carcinoma patients: a real-world research.

Authors:  Lei Liu; Jiaqi Zhang; Guige Wang; Chao Guo; Yeye Chen; Cheng Huang; Shanqing Li
Journal:  J Cardiothorac Surg       Date:  2020-09-25       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.